Ypsomed Collaborated with CamDiab for Smartphone-based Automated Insulin Delivery
On March 22, 2022, Ypsomed, a leading manufacturer of injection and infusion systems for self-medication partnered with CamDiab Ltd, developer of CamAPS FX, an app for the management of glucose levels via insulin pumps using an adaptive, hybrid closed-loop approach. The easy-to-use loop solution is expected to be launched during the first half of 2022 for the mylife YpsoPump system in selected major countries in Europe and followed by other territories in the course of the year.
With this partnership, the world-leading, adaptive, hybrid closed-loop solution provided by CamDia...
